Nov 20, 2026 · 2 min read · Industry News
Ascletis Files IND for an Oral Quadruple Peptide Agonist
Ascletis submitted a US IND for ASC36_37o, a once-weekly oral amylin plus GLP-1/GIP/glucagon peptide combination. Data so far are preclinical.
EvoX Biolabs sells research compounds for laboratory use only. You must be 21 or older to enter.
For research use only. Not for human or animal consumption.
For research use only. Not for human or animal consumption. Ships to US addresses only.
Nov 20, 2026 · 2 min read · Industry News
Ascletis submitted a US IND for ASC36_37o, a once-weekly oral amylin plus GLP-1/GIP/glucagon peptide combination. Data so far are preclinical.